Stock Screener · Library
Monte Rosa Therapeutics, Inc. financial statement history
Source-linked financial facts for Monte Rosa Therapeutics, Inc. with exact reported periods, units and filing dates. Historical periods ending 2021–2025.
What this record covers
This historical reference uses a locally cached SEC companyfacts snapshot and reports periods ending from 2021 through 2025. It is not a current quotation feed, a screening recommendation or a verification of the company's present condition.
Each value retains its reported unit and exact period. Filing fiscal year describes the submitting filing and can differ from the year of a comparative fact. Values with different currencies or period boundaries are not combined.
Total assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 366329000 | USD | 2023-03-16 | 2022 / FY | us-gaap:Assets | 10-K · 0000950170-23-008440 |
| As of 2022-12-31 | 342389000 | USD | 2024-03-14 | 2023 / FY | us-gaap:Assets | 10-K · 0000950170-24-031150 |
| As of 2023-12-31 | 303755000 | USD | 2025-03-20 | 2024 / FY | us-gaap:Assets | 10-K · 0000950170-25-042344 |
| As of 2024-12-31 | 438732000 | USD | 2026-03-17 | 2025 / FY | us-gaap:Assets | 10-K · 0001193125-26-109360 |
| As of 2025-12-31 | 448659000 | USD | 2026-03-17 | 2025 / FY | us-gaap:Assets | 10-K · 0001193125-26-109360 |
Current assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 348666000 | USD | 2023-03-16 | 2022 / FY | us-gaap:AssetsCurrent | 10-K · 0000950170-23-008440 |
| As of 2022-12-31 | 275886000 | USD | 2024-03-14 | 2023 / FY | us-gaap:AssetsCurrent | 10-K · 0000950170-24-031150 |
| As of 2023-12-31 | 236212000 | USD | 2025-03-20 | 2024 / FY | us-gaap:AssetsCurrent | 10-K · 0000950170-25-042344 |
| As of 2024-12-31 | 377440000 | USD | 2026-03-17 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001193125-26-109360 |
| As of 2025-12-31 | 393185000 | USD | 2026-03-17 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001193125-26-109360 |
Cash and cash equivalents
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 346071000 | USD | 2023-03-16 | 2022 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0000950170-23-008440 |
| As of 2022-12-31 | 54912000 | USD | 2024-03-14 | 2023 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0000950170-24-031150 |
| As of 2023-12-31 | 128101000 | USD | 2025-03-20 | 2024 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0000950170-25-042344 |
| As of 2024-12-31 | 224254000 | USD | 2026-03-17 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001193125-26-109360 |
| As of 2025-12-31 | 129883000 | USD | 2026-03-17 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001193125-26-109360 |
Property, plant and equipment
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 12325000 | USD | 2023-03-16 | 2022 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0000950170-23-008440 |
| As of 2022-12-31 | 27075000 | USD | 2024-03-14 | 2023 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0000950170-24-031150 |
| As of 2023-12-31 | 33803000 | USD | 2025-03-20 | 2024 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0000950170-25-042344 |
| As of 2024-12-31 | 29483000 | USD | 2026-03-17 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001193125-26-109360 |
| As of 2025-12-31 | 25986000 | USD | 2026-03-17 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001193125-26-109360 |
Total liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 18814000 | USD | 2023-03-16 | 2022 / FY | us-gaap:Liabilities | 10-K · 0000950170-23-008440 |
| As of 2022-12-31 | 70976000 | USD | 2024-03-14 | 2023 / FY | us-gaap:Liabilities | 10-K · 0000950170-24-031150 |
| As of 2023-12-31 | 124505000 | USD | 2025-03-20 | 2024 / FY | us-gaap:Liabilities | 10-K · 0000950170-25-042344 |
| As of 2024-12-31 | 215796000 | USD | 2026-03-17 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001193125-26-109360 |
| As of 2025-12-31 | 215603000 | USD | 2026-03-17 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001193125-26-109360 |
Current liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 16638000 | USD | 2023-03-16 | 2022 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0000950170-23-008440 |
| As of 2022-12-31 | 25569000 | USD | 2024-03-14 | 2023 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0000950170-24-031150 |
| As of 2023-12-31 | 46592000 | USD | 2025-03-20 | 2024 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0000950170-25-042344 |
| As of 2024-12-31 | 156946000 | USD | 2026-03-17 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001193125-26-109360 |
| As of 2025-12-31 | 64212000 | USD | 2026-03-17 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001193125-26-109360 |
Stockholders equity
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 347515000 | USD | 2024-03-14 | 2023 / FY | us-gaap:StockholdersEquity | 10-K · 0000950170-24-031150 |
| As of 2022-12-31 | 271413000 | USD | 2025-03-20 | 2024 / FY | us-gaap:StockholdersEquity | 10-K · 0000950170-25-042344 |
| As of 2023-12-31 | 179250000 | USD | 2026-03-17 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001193125-26-109360 |
| As of 2024-12-31 | 222936000 | USD | 2026-03-17 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001193125-26-109360 |
| As of 2025-12-31 | 233056000 | USD | 2026-03-17 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001193125-26-109360 |
Research and development
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 57155000 | USD | 2023-03-16 | 2022 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0000950170-23-008440 |
| 2022-01-01 to 2022-12-31 | 85061000 | USD | 2024-03-14 | 2023 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0000950170-24-031150 |
| 2023-01-01 to 2023-12-31 | 111272000 | USD | 2025-03-20 | 2024 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0000950170-25-042344 |
| 2024-01-01 to 2024-12-31 | 121563000 | USD | 2026-03-17 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001193125-26-109360 |
| 2025-01-01 to 2025-12-31 | 141500000 | USD | 2026-03-17 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001193125-26-109360 |
Operating income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -72882000 | USD | 2023-03-16 | 2022 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0000950170-23-008440 |
| 2022-01-01 to 2022-12-31 | -112384000 | USD | 2024-03-14 | 2023 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0000950170-24-031150 |
| 2023-01-01 to 2023-12-31 | -143311000 | USD | 2025-03-20 | 2024 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0000950170-25-042344 |
| 2024-01-01 to 2024-12-31 | -81112000 | USD | 2026-03-17 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001193125-26-109360 |
| 2025-01-01 to 2025-12-31 | -54208000 | USD | 2026-03-17 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001193125-26-109360 |
Net income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -73958000 | USD | 2023-03-16 | 2022 / FY | us-gaap:NetIncomeLoss | 10-K · 0000950170-23-008440 |
| 2022-01-01 to 2022-12-31 | -108501000 | USD | 2024-03-14 | 2023 / FY | us-gaap:NetIncomeLoss | 10-K · 0000950170-24-031150 |
| 2023-01-01 to 2023-12-31 | -135352000 | USD | 2025-03-20 | 2024 / FY | us-gaap:NetIncomeLoss | 10-K · 0000950170-25-042344 |
| 2024-01-01 to 2024-12-31 | -72700000 | USD | 2026-03-17 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001193125-26-109360 |
| 2025-01-01 to 2025-12-31 | -38626000 | USD | 2026-03-17 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001193125-26-109360 |
Operating cash flow
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -59363000 | USD | 2023-03-16 | 2022 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0000950170-23-008440 |
| 2022-01-01 to 2022-12-31 | -92466000 | USD | 2024-03-14 | 2023 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0000950170-24-031150 |
| 2023-01-01 to 2023-12-31 | -43802000 | USD | 2025-03-20 | 2024 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0000950170-25-042344 |
| 2024-01-01 to 2024-12-31 | 41996000 | USD | 2026-03-17 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001193125-26-109360 |
| 2025-01-01 to 2025-12-31 | -22798000 | USD | 2026-03-17 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001193125-26-109360 |
Capital expenditure
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 9732000 | USD | 2023-03-16 | 2022 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0000950170-23-008440 |
| 2022-01-01 to 2022-12-31 | 12911000 | USD | 2024-03-14 | 2023 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0000950170-24-031150 |
| 2023-01-01 to 2023-12-31 | 19041000 | USD | 2025-03-20 | 2024 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0000950170-25-042344 |
| 2024-01-01 to 2024-12-31 | 3988000 | USD | 2026-03-17 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001193125-26-109360 |
| 2025-01-01 to 2025-12-31 | 4700000 | USD | 2026-03-17 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001193125-26-109360 |
Dividends paid
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 0 | USD | 2022-03-29 | 2021 / FY | us-gaap:PaymentsOfDividends | 10-K · 0000950170-22-004927 |
| 2022-01-01 to 2022-12-31 | 0 | USD | 2023-03-16 | 2022 / FY | us-gaap:PaymentsOfDividends | 10-K · 0000950170-23-008440 |
| 2023-01-01 to 2023-12-31 | 0 | USD | 2024-03-14 | 2023 / FY | us-gaap:PaymentsOfDividends | 10-K · 0000950170-24-031150 |
| 2024-01-01 to 2024-12-31 | 0 | USD | 2025-03-20 | 2024 / FY | us-gaap:PaymentsOfDividends | 10-K · 0000950170-25-042344 |
| 2025-01-01 to 2025-12-31 | 0 | USD | 2026-03-17 | 2025 / FY | us-gaap:PaymentsOfDividends | 10-K · 0001193125-26-109360 |
Source and method
SEC public numeric facts are reorganized into a standard reference. Tag priority follows the native app's declared concept chains; the latest filed observation is selected within the same exact start, end and unit. A missing value stays missing. No currency, quarterly total, ratio, share-price series or dividend calendar is inferred.
The ticker below belongs to the native source snapshot. Company names, tickers and reporting structures may change; CIK identifies the source filer.
- Source filer CIK
- 1826457
- Ticker in native snapshot
- GLUE
- Reported numeric facts
- 65
- Units present
- USD